US Stock MarketDetailed Quotes

MiNK Therapeutics (INKT)

Watchlist
  • 11.950
  • +0.050+0.42%
Close Dec 26 16:00 ET
  • 12.217
  • +0.267+2.24%
Post 18:42 ET
56.10MMarket Cap-3.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MiNK Therapeutics (INKT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
75.48%2.99M
27.11%3.69M
-33.87%2.53M
-53.54%10.65M
-59.73%2.21M
-67.38%1.7M
-54.26%2.9M
-34.58%3.83M
-25.94%22.92M
-30.28%5.5M
Selling and administrative expenses
58.77%1.85M
74.15%1.85M
-0.75%1.27M
-41.94%4.31M
-63.05%808.9K
-35.25%1.16M
-40.51%1.06M
-22.89%1.28M
-5.14%7.43M
5.40%2.19M
-General and administrative expense
58.77%1.85M
74.15%1.85M
-0.75%1.27M
-41.94%4.31M
-63.05%808.9K
-35.25%1.16M
-40.51%1.06M
-22.89%1.28M
-5.14%7.43M
5.40%2.19M
Research and development costs
111.45%1.14M
-0.04%1.84M
-50.50%1.26M
-59.10%6.34M
-57.53%1.41M
-84.23%540.64K
-59.64%1.84M
-39.20%2.55M
-32.99%15.49M
-43.04%3.31M
Operating profit
-75.48%-2.99M
-27.11%-3.69M
33.87%-2.53M
53.54%-10.65M
59.73%-2.21M
67.38%-1.7M
54.26%-2.9M
34.58%-3.83M
25.94%-22.92M
30.28%-5.5M
Net non-operating interest income expense
-29.31%55.15K
-99.09%348
-18.67%13.52K
-62.75%172.57K
-4.70%39.57K
-27.28%78.02K
-73.80%38.36K
-90.11%16.62K
82.87%463.26K
-69.20%41.53K
Non-operating interest income
-29.31%55.15K
-99.09%348
-18.67%13.52K
-62.75%172.57K
-4.70%39.57K
-27.28%78.02K
-73.80%38.36K
-90.11%16.62K
82.87%463.26K
-69.20%41.53K
Other net income (expense)
125.87%46.81K
-440.43%-549.79K
-247.45K
-3,071,210.00%-307.13K
-1,598,183.33%-287.69K
-2,261,862.50%-180.94K
161.5K
-100.00%-10
99.88%-18
Gain on sale of security
-7.17%-193.92K
-114.91%-364.09K
---167.92K
---638.05K
---287.69K
---180.94K
---169.41K
----
----
----
Other non- operating income (expenses)
--240.73K
-156.12%-185.7K
---79.53K
3,309,250.00%330.92K
--0
----
--330.92K
----
-100.00%-10
99.88%-18
Income before tax
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
Income tax
Net income
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
Net income continuous Operations
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
Minority interest income
Net income attributable to the parent company
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
51.98%-10.78M
54.88%-2.46M
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
Basic earnings per share
-41.30%-0.65
-45.21%-1.06
36.36%-0.7
56.27%-2.86
59.74%-0.62
69.33%-0.46
59.44%-0.73
35.29%-1.1
21.20%-6.54
33.04%-1.54
Diluted earnings per share
-41.30%-0.65
-45.21%-1.06
36.36%-0.7
56.27%-2.86
59.74%-0.62
69.33%-0.46
59.44%-0.73
35.29%-1.1
21.20%-6.54
33.04%-1.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 75.48%2.99M27.11%3.69M-33.87%2.53M-53.54%10.65M-59.73%2.21M-67.38%1.7M-54.26%2.9M-34.58%3.83M-25.94%22.92M-30.28%5.5M
Selling and administrative expenses 58.77%1.85M74.15%1.85M-0.75%1.27M-41.94%4.31M-63.05%808.9K-35.25%1.16M-40.51%1.06M-22.89%1.28M-5.14%7.43M5.40%2.19M
-General and administrative expense 58.77%1.85M74.15%1.85M-0.75%1.27M-41.94%4.31M-63.05%808.9K-35.25%1.16M-40.51%1.06M-22.89%1.28M-5.14%7.43M5.40%2.19M
Research and development costs 111.45%1.14M-0.04%1.84M-50.50%1.26M-59.10%6.34M-57.53%1.41M-84.23%540.64K-59.64%1.84M-39.20%2.55M-32.99%15.49M-43.04%3.31M
Operating profit -75.48%-2.99M-27.11%-3.69M33.87%-2.53M53.54%-10.65M59.73%-2.21M67.38%-1.7M54.26%-2.9M34.58%-3.83M25.94%-22.92M30.28%-5.5M
Net non-operating interest income expense -29.31%55.15K-99.09%348-18.67%13.52K-62.75%172.57K-4.70%39.57K-27.28%78.02K-73.80%38.36K-90.11%16.62K82.87%463.26K-69.20%41.53K
Non-operating interest income -29.31%55.15K-99.09%348-18.67%13.52K-62.75%172.57K-4.70%39.57K-27.28%78.02K-73.80%38.36K-90.11%16.62K82.87%463.26K-69.20%41.53K
Other net income (expense) 125.87%46.81K-440.43%-549.79K-247.45K-3,071,210.00%-307.13K-1,598,183.33%-287.69K-2,261,862.50%-180.94K161.5K-100.00%-1099.88%-18
Gain on sale of security -7.17%-193.92K-114.91%-364.09K---167.92K---638.05K---287.69K---180.94K---169.41K------------
Other non- operating income (expenses) --240.73K-156.12%-185.7K---79.53K3,309,250.00%330.92K--0------330.92K-----100.00%-1099.88%-18
Income before tax -59.84%-2.89M-56.85%-4.24M27.45%-2.77M51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M
Income tax
Net income -59.84%-2.89M-56.85%-4.24M27.45%-2.77M51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M
Net income continuous Operations -59.84%-2.89M-56.85%-4.24M27.45%-2.77M51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M
Minority interest income
Net income attributable to the parent company -59.84%-2.89M-56.85%-4.24M27.45%-2.77M51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -59.84%-2.89M-56.85%-4.24M27.45%-2.77M51.98%-10.78M54.88%-2.46M64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M
Basic earnings per share -41.30%-0.65-45.21%-1.0636.36%-0.756.27%-2.8659.74%-0.6269.33%-0.4659.44%-0.7335.29%-1.121.20%-6.5433.04%-1.54
Diluted earnings per share -41.30%-0.65-45.21%-1.0636.36%-0.756.27%-2.8659.74%-0.6269.33%-0.4659.44%-0.7335.29%-1.121.20%-6.5433.04%-1.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +1.02%
Sample Name
Sample Code
 +0.89%
Sample Name
Sample Code
 +0.86%
4
Palo Alto Networks
PANW
+0.66%
5
Broadcom
AVGO
+0.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.72%
Sample Name
Sample Code
 +8.72%
Sample Name
Sample Code
 +7.79%
4
Zai Lab
ZLAB
+6.69%
5
Taiwan Semiconductor
TSM
+6.38%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -